These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 1825313)

  • 1. The use of protease inhibitors in experimental allergic neuritis.
    Schabet M; Whitaker JN; Schott K; Stevens A; Zürn A; Bühler R; Wiethölter H
    J Neuroimmunol; 1991 Mar; 31(3):265-72. PubMed ID: 1825313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Observations on the effects of protease inhibitors on the suppression of experimental allergic encephalomyelitis.
    Smith ME; Amaducci LA
    Neurochem Res; 1982 May; 7(5):541-54. PubMed ID: 6750429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteolysis of peripheral nerve myelin in acute experimental allergic neuritis.
    Schott K; Schabet M; Stevens A; Bühler R; Wiethölter H
    Neurochem Res; 1990 Sep; 15(9):855-9. PubMed ID: 2274098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Demyelination of sciatic nerve in acute experimental allergic neuritis of the rat. A gel electrophoresis investigation.
    Schott K; Jenner A; Wiethölter H; Schabet M; Stevens A
    J Neuroimmunol; 1988 Nov; 20(1):53-61. PubMed ID: 3263390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of experimental allergic neuritis with nedocromil sodium.
    Seeldrayers PA; Yasui D; Weiner HL; Johnson D
    J Neuroimmunol; 1989 Dec; 25(2-3):221-6. PubMed ID: 2479661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic effect of transforming growth factor-beta 2 on actively induced EAN but not adoptive transfer EAN.
    Jung S; Schluesener HJ; Schmidt B; Fontana A; Toyka KV; Hartung HP
    Immunology; 1994 Dec; 83(4):545-51. PubMed ID: 7533133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of experimental allergic encephalomyelitis with an inhibitor of cathepsin D (pepstatin).
    Boehme DH; Umezawa H; Hashim G; Marks N
    Neurochem Res; 1978 Apr; 3(2):185-94. PubMed ID: 307703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphatidylserine suppresses myelin-induced experimental allergic neuritis (EAN) in Lewis rats.
    Maeda Y; Maeda R; Prineas JW; Ledeen RW
    J Neuropathol Exp Neurol; 1994 Nov; 53(6):672-7. PubMed ID: 7964907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of macrophages and eicosanoids in the pathogenesis of experimental allergic neuritis. Serial clinical, electrophysiological, biochemical and morphological observations.
    Hartung HP; Schäfer B; Heininger K; Stoll G; Toyka KV
    Brain; 1988 Oct; 111 ( Pt 5)():1039-59. PubMed ID: 2846115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FTY720 controls disease severity and attenuates sciatic nerve damage in chronic experimental autoimmune neuritis.
    Kremer L; Taleb O; Boehm N; Mensah-Nyagan AG; Trifilieff E; de Seze J; Brun S
    J Neuroinflammation; 2019 Mar; 16(1):54. PubMed ID: 30825874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of endoneural cells in experimental allergic neuritis and characterisation of a resident phagocytic cell.
    Stevens A; Schabet M; Schott K; Wiethölter H
    Acta Neuropathol; 1989; 77(4):412-9. PubMed ID: 2785326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Laquinimod exerts strong clinical and immunomodulatory effects in Lewis rat experimental autoimmune neuritis.
    Pitarokoili K; Ambrosius B; Schrewe L; Hayardeny L; Hayden M; Gold R
    J Neuroimmunol; 2014 Sep; 274(1-2):38-45. PubMed ID: 25005118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of experimental allergic neuritis with prednisolone.
    Feasby TE; Gilbert JJ; Hahn AF; Lovgren DS
    Can J Neurol Sci; 1987 Feb; 14(1):46-9. PubMed ID: 3493057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intranasal administration of recombinant mouse interleukin-12 increases inflammation and demyelination in chronic experimental autoimmune neuritis in Lewis rats.
    Pelidou SH; Zou LP; Deretzi G; Nennesmo I; Wei L; Mix E; Van Der Meide PH; Zhu J
    Scand J Immunol; 2000 Jan; 51(1):29-35. PubMed ID: 10632973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soluble complement receptor 1 (sCR1) is not as effective as cobra venom factor in the treatment of experimental allergic neuritis.
    Vriesendorp FJ; Flynn RE; Pappolla MA; Koski CL
    Int J Neurosci; 1997 Dec; 92(3-4):287-98. PubMed ID: 9522271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resolvin D1 Programs Inflammation Resolution by Increasing TGF-β Expression Induced by Dying Cell Clearance in Experimental Autoimmune Neuritis.
    Luo B; Han F; Xu K; Wang J; Liu Z; Shen Z; Li J; Liu Y; Jiang M; Zhang ZY; Zhang Z
    J Neurosci; 2016 Sep; 36(37):9590-603. PubMed ID: 27629711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peripheral nervous system demyelination from systemic transfer of experimental allergic neuritis serum.
    Harvey GK; Pollard JD
    J Neuroimmunol; 1992 Dec; 41(2):159-66. PubMed ID: 1334966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of experimental autoimmune neuritis by leflunomide.
    Korn T; Toyka K; Hartung HP; Jung S
    Brain; 2001 Sep; 124(Pt 9):1791-802. PubMed ID: 11522581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of ion channel blockers on immune response and course of experimental allergic neuritis.
    Mix E; Olsson T; Solders G; Link H
    Brain; 1989 Dec; 112 ( Pt 6)():1405-18. PubMed ID: 2480831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective elimination of macrophages by dichlormethylene diphosphonate-containing liposomes suppresses experimental autoimmune neuritis.
    Jung S; Huitinga I; Schmidt B; Zielasek J; Dijkstra CD; Toyka KV; Hartung HP
    J Neurol Sci; 1993 Nov; 119(2):195-202. PubMed ID: 8277335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.